Here we present the results of STEMS, a prospective, therapeutic exploratory, non-randomized, open-label, single-dose-finding phase 1 clinical trial (NCT03269071, EudraCT 2016-002020-86), performed at San Raffaele Hospital in Milan, Italy, evaluating the feasibility, safety and tolerability of intrathecally transplanted human fetal NPCs ( hf NPCs) in 12 patients with PMS (with evidence of disease progression, Expanded Disability Status Scale 6.5, age 1855 years, disease duration 220 years, without any alternative approved therapy)
It is normal for appetite suppression to feel slightly less intense on day six or seven
No prescription needed.* 5
Semaglutide mimics the effects of GLP-1 and has shown promising results when it comes to slimming down
Neurology , 96 , e1012e1023
BMC Public Health 15, 76